FDA May Allow Over-The-Counter Sale of "Morning After" Abortion Pill
A comment period is currently underway as the Food and Drug Administration (FDA) considers changing the status of the abortion-causing "morning-after" pill from prescription-only to over-the-counter sales.

Our friends on Capitol Hill have asked us to alert pro-life citizens who wish to comment on the proposed policy change, that the information put out by the FDA for submitting comments on the change in policy is incorrect.

Do not follow the advertised information, which appears on the FDA web site and says, "Addresses: Electronic comments should be submitted to http://www.fda.gov/dockets/ecomments. Select '01P-0075-Switch Status of Emergency Contraceptives from Rx to OTC’ and follow the prompts to submit your statement."

The so-called "morning-after," or "emergency contraceptive" drug, should not have been approved by the FDA in the first place. Its mode of action is to make the lining of the uterine wall inhospitable to the developing baby, causing him to be expelled in an early abortion.

In addition, the drug contains powerful hormones that can be dangerous to the health of women and girls, who, thinking they might be pregnant, must currently see a doctor before obtaining a prescription. If the drug is readily available over-the-counter, it is likely to lead to some very serious health consequences for the mothers as well as for their babies, who will certainly die.

Legislation to Bar RU-486 Introduced in Congress Senator Sam Brownback (R-KS) and Rep. Jim DeMint (R-SC), both pro-life stalwarts, have introduced H.R. 3453, a bill that would suspend marketing of the abortion-causing drug RU-486, which was developed by a French company and ultimately manufactured in Communist China for sale in the United States.

The bill instructs the General Accounting office (GAO) to investigate the process through which the FDA approved RU-486. After years of sustained and successful protest by pro-life citizens against importation of the drug into the U.S., FDA approval came swiftly in the final days of the Clinton administration. H.R. 3453 requires that the GAO’s Comptroller General to report to Congress and to the Secretary of Health and Human Services, Tommy Thompson, his finding of whether the drug was approved under the requirements of the law which governs the FDA.

The FDA determined the safety and efficacy of RU-486, despite volumes evidence to the contrary, through a "fast track" process, which is typically used only for drugs that are expected to render help to people stricken with life-threatening and catastrophic diseases or conditions.

The RU-486 issue has gained momentum recently because of the death of Holly Patterson, a California teenager who died after being given the drug by Planned Parenthood without the knowledge of her parents. Mr. and Mrs. Patterson have asked that the DeMint/Brownback bill be named "Holly’s Law."

If you would like to make a contribution to support our work, please
send your donation to:
RNC/Life - P.O. Box 618 - Alton, IL 62002
Or you may charge your contribution on Master Card or Visa by calling
618/462-5415.
(Contributions are not tax-deductible)